Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Nath Bio-Genes (India) Financial Results

Nath Bio-Genes (India) Ltd reported consolidated annual revenue of ₹445.10 Crore for FY26. The Board recommended a dividend of ₹2 per share (20%) and approved the reappointment of Mr. Hitesh Rajnikant Purohit as an Independent Director for a second five-year term starting March 2027.

Key figures
Value₹445.1 Cr
Source

BSE filing, NSE: NATHBIOGEN. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Nath Bio-Genes (India) Ltd: key numbers

Share price
₹133.10
Market cap
₹252.9 Cr
Revenue (annual)
₹445.1 Cr
Net profit (annual)
₹41.63 Cr
P/E (TTM)
6.9×Sector 26.2×
Promoter holding
45.60%+0.00% QoQ
FII holding
0.18%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Nath Bio-Genes (India) Ltd

All →

Other financial results announcements

All →